Screener
Schrodinger SDGR Contribution — Unsatisfied performance obligation
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Schrodinger in its filing.
Tagged under the XBRL concept us-gaap:RevenueRemainingPerformanceObligation.
The source filing: Schrodinger’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001490978-26-000068
| Deferred revenue | As of June 30, 2026 / Total | As of December 31, 2025 / Total |
|---|---|---|
| Drug discovery | 8,598 | 17,100 |
| Contribution | — | — |
| Total backlog | 39,141 | 48,136 |
| Remaining performance obligations | ||
| Software products and services | 87,156 | 105,064 |
| Drug discovery | 97,769 | 134,671 |
| Contribution | 4,141 | 131 |
| Total remaining performance obligations | $189,066 | $239,866 |
Item 1. Financial Statements.
FAQ
- What is Schrodinger's contribution — unsatisfied performance obligation?
- Schrodinger (SDGR) reported contribution — unsatisfied performance obligation of $4.14M in Q2 2026.
- What does contribution — unsatisfied performance obligation mean?
- Quantifies the value of contractual obligations that the company has committed to perform but has not yet completed. This metric helps investors assess the company's future work commitments and revenue visibility.
Ask your AI about Schrodinger's contribution — unsatisfied performance obligation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude